Geode Capital Management, LLC Incyte Corp Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Incyte Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,046,638 shares of INCY stock, worth $308 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,046,638

Previous 4,439,896 8.86%

Holding current value

$308 Million

Previous $253 Million 3.02%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$51.18 - $63.75 $20.1 Million - $25.1 Million	-393,258 Reduced 8.86%	4,046,638 $245 Million
Q1 2024 May 13, 2024	BUY	$56.55 - $66.59 $9.41 Million - $11.1 Million	166,448 Added 3.89%	4,439,896 $253 Million
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $5.53 Million - $6.8 Million	105,954 Added 2.54%	4,273,448 $268 Million
Q3 2023 Nov 13, 2023	BUY	$57.77 - $65.93 $5.2 Million - $5.93 Million	90,004 Added 2.21%	4,167,494 $241 Million
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $7.05 Million - $8.74 Million	115,748 Added 2.92%	4,077,490 $254 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $6.55 Million - $8.03 Million	93,329 Added 2.41%	3,961,742 $286 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $6.62 Million - $8.29 Million	98,552 Added 2.61%	3,868,413 $310 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $2.49 Million - $3.12 Million	37,595 Added 1.01%	3,769,861 $251 Million
Q2 2022 Aug 12, 2022	BUY	$66.18 - $83.18 $4.18 Million - $5.26 Million	63,181 Added 1.72%	3,732,266 $283 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $12.5 Million - $15.1 Million	-189,057 Reduced 4.9%	3,669,085 $291 Million
Q4 2021 Feb 11, 2022	BUY	$63.34 - $74.11 $2.05 Million - $2.4 Million	32,423 Added 0.85%	3,858,142 $283 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $13.7 Million - $16.8 Million	199,662 Added 5.51%	3,825,719 $263 Million
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $19.4 Million - $21.3 Million	242,831 Added 7.18%	3,626,057 $304 Million
Q1 2021 May 12, 2021	BUY	$76.02 - $100.5 $9.79 Million - $12.9 Million	128,752 Added 3.96%	3,383,226 $274 Million
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $3.3 Million - $4 Million	40,909 Added 1.27%	3,254,474 $282 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $7.71 Million - $9.95 Million	90,682 Added 2.9%	3,213,565 $288 Million
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $8.6 Million - $12.6 Million	115,884 Added 3.85%	3,122,883 $324 Million
Q1 2020 May 14, 2020	BUY	$63.18 - $85.97 $3.04 Million - $4.13 Million	48,044 Added 1.62%	3,006,999 $220 Million
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $7.88 Million - $10.3 Million	107,912 Added 3.79%	2,958,955 $258 Million
Q3 2019 Nov 12, 2019	BUY	$72.82 - $86.52 $16.8 Million - $19.9 Million	230,226 Added 8.78%	2,851,043 $211 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $8.29 Million - $10 Million	112,804 Added 4.5%	2,620,817 $222 Million
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $9.37 Million - $13 Million	147,407 Added 6.24%	2,508,013 $215 Million
Q4 2018 Feb 13, 2019	BUY	$58.5 - $69.94 $9.74 Million - $11.6 Million	166,510 Added 7.59%	2,360,606 $150 Million
Q3 2018 Nov 13, 2018	BUY	$61.75 - $74.23 $3.16 Million - $3.8 Million	51,253 Added 2.39%	2,194,096 $151 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $4.59 Million - $6.33 Million	75,402 Added 3.65%	2,142,843 $143 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $10.7 Million - $13 Million	129,203 Added 6.67%	2,067,441 $172 Million
Q4 2017 Feb 13, 2018	BUY	$93.56 - $116.6 $9.89 Million - $12.3 Million	105,692 Added 5.77%	1,938,238 $183 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $5.16 Million - $6.53 Million	47,232 Added 2.65%	1,832,546 $214 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,785,314	1,785,314 $224 Million

Others Institutions Holding INCY

# of Institutions

624

Shares Held

198M

Call Options Held

766K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Incyte Corp Transaction History